Arrowhead Pharmaceuticals Inc (ARWR)
$59.90 -0.98% Close Oct 30, 2026 Live
Arrowhead Pharmaceuticals stock today
Arrowhead Pharmaceuticals closed at $59.90 on October 30, 2026, down 0.98% on the day. Over the past year it returned +41.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.44 billion.
$40.00$60.00$80.00
NovJan 2026MarMayJulSep
| Period | ARWR | S&P 500 (SPY) |
|---|---|---|
| 1 month | -8.5% | -0.9% |
| 3 months | -31.4% | +2.1% |
| Year to date | -9.8% | +11.7% |
| 1 year | +41.6% | +12.4% |
| 3 years | +158.0% | +88.5% |
| 5 years | -6.1% | +76.0% |
Key statistics
- Market value
- $8.44B
- Price / sales
- 12.6
- 52-week range
- $37.85 to $89.59
- Next report
- Nov 24, 2026
About Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops RNA-based therapies for genetic diseases and other conditions.
Sector: Health Care
More on Arrowhead Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +23,258% in the year to Sep 2025
- Returns: what $1,000 became$1,000 ten years ago is $10,213 today
No forecast, no recommendation. This page describes Arrowhead Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.